US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VistaGen Therapeutics

3.60

-0.8300-18.74%

Post-market: 3.60-0.0013-0.04%17:39 EST

Volume:1.53M

Turnover:5.99M

Market Cap:142.18M

PE:-1.88

High:4.42

Open:4.41

Low:3.54

Close:4.43

52wk High:5.14

52wk Low:1.90

Shares:39.50M

Float Shares:30.75M

Volume Ratio:1.70

T/O Rate:4.98%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9154

EPS(LYR):-1.6652

ROE:-78.13%

ROA:-44.62%

PB:2.14

PE(LYR):-2.16

Loading ...

Overview Company News Filings

BRIEF-Vistagen Appoints Nick Tressler As Chief Financial Officer

Vistagen Appoints Nick Tressler as Chief Financial Officer

THOMSON REUTERS

Vistagen presents exploratory PH80 data at Menopause Society meeting

VistaGen Unveils Rapid-Acting PH80 Nasal Spray Data for Menopausal Hot Flashes at Menopause Society Meeting

VistaGen Q2 EPS USD -0.54

VistaGen Therapeutics: Buy Rating Backed by Promising Clinical Trials and Stable Financial Outlook

VistaGen Therapeutics: Buy Rating Affirmed Amid Promising Fasedienol Trials and Market Potential

Biopharmaceutical firm VistaGen's fiscal Q2 net loss widens

BRIEF-VistaGen Q2 EPS USD -0.54

VistaGen Therapeutics reports fiscal Q2 net loss and higher R&D expenses

Press Release: Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025

VistaGen Therapeutics Inc. to Release Fiscal Year 2026 Second Quarter Results

VistaGen Therapeutics CEO to Join Stifel Healthcare Conference Fireside Chat

VistaGen Therapeutics Inc. Files Initial Beneficial Ownership Statement for Director Paul R. Edick

VistaGen Therapeutics: Promising Prospects for Fasedienol in Social Anxiety Disorder

Assessing Vistagen Therapeutics’s (VTGN) Valuation After Board Addition of Pharma Executive Paul Edick

Simply Wall St.

Vistagen Therapeutics Inc - Completes Palisade-3 Phase 3 Study for Social Anxiety

THOMSON REUTERS

Vistagen Therapeutics Inc - Topline Results Expected by Year End

THOMSON REUTERS

VistaGen Completes Phase 3 Trial of Fasedienol for Social Anxiety Disorder

William Blair Remains a Buy on VistaGen Therapeutics (VTGN)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VTGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VTGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","market":"US","secType":"STK","nameCN":"VistaGen Therapeutics","latestPrice":3.6,"timestamp":1764709200000,"preClose":4.43,"halted":0,"volume":1531282,"hourTrading":{"tag":"盘后","latestPrice":3.5987,"preClose":3.6,"latestTime":"17:39 EST","volume":8879,"amount":31982.413715199997,"timestamp":1764715149648},"delay":0,"floatShares":30750300,"shares":39495451,"eps":-1.915353,"marketStatus":"Post-Mkt","change":-0.83,"latestTime":"12-02 17:44:05 EST","open":4.41,"high":4.42,"low":3.535,"amount":5986906.3708854,"amplitude":0.199774,"askPrice":3.86,"askSize":100,"bidPrice":3.59,"bidSize":19,"shortable":0,"etf":0,"ttmEps":-1.915353,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1764723600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1462939200000,"exchange":"NASDAQ","adjPreClose":4.43,"preHourTrading":{"tag":"盘前","latestPrice":4.437,"preClose":4.43,"latestTime":"08:50 EST","volume":3584,"amount":15921.7035264,"timestamp":1764683438772},"postHourTrading":{"tag":"盘后","latestPrice":3.5987,"preClose":3.6,"latestTime":"17:39 EST","volume":8879,"amount":31982.413715199997,"timestamp":1764715149648},"volumeRatio":1.700824,"impliedVol":3.3912,"impliedVolPercentile":0.908},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","floatShares":30750300,"roa":"-44.62%","roe":"-78.13%","lyrEps":-1.66525,"volumeRatio":1.700824,"shares":39495451,"dividePrice":0,"high":4.42,"amplitude":0.199774,"preClose":4.43,"low":3.535,"week52Low":1.9,"pbRate":"2.14","psRate":"197.20","week52High":5.14,"institutionHeld":0,"latestPrice":3.6,"committee":-0.680672,"eps":-1.915353,"divideRate":0,"volume":1531282,"delay":0,"ttmEps":-1.915353,"open":4.41,"prevYearClose":2.95,"prevWeekClose":4.9,"prevMonthClose":4.9,"prevQuarterClose":3.55,"fiveDayClose":4.72,"twentyDayClose":4.24,"sixtyDayClose":3.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VTGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"VTGN","fiscalQuarterEnding":"2025/09","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2025-08-07","symbol":"VTGN","fiscalQuarterEnding":"2025/06","expectedEps":-0.47,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.47},{"market":"US","date":"2025-06-17","symbol":"VTGN","fiscalQuarterEnding":"2025/03","expectedEps":-0.52,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1750132800000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2025-02-13","symbol":"VTGN","fiscalQuarterEnding":"2024/12","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2024-11-07","symbol":"VTGN","fiscalQuarterEnding":"2024/09","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.42}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VTGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VTGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1756962000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VTGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VTGN","date":"2025-12-01","current":-1.879549,"percent":0.453583,"low":-37.785134,"twenty":-11.864307,"median":-2.526839,"eighty":-0.737322,"high":-0.195082,"avg":-6.916813,"sd":9.212401,"marketCap":193527709},"quantilePoints":[{"date":"2020-12-04","current":-3.630693,"twenty":-2.266793,"median":-1.47671,"eighty":-0.742724,"marketCap":56830507},{"date":"2020-12-11","current":-3.474686,"twenty":-2.279445,"median":-1.498443,"eighty":-0.742724,"marketCap":54388571},{"date":"2020-12-18","current":-11.903133,"twenty":-2.291259,"median":-1.520919,"eighty":-0.742724,"marketCap":186317357},{"date":"2020-12-24","current":-12.212852,"twenty":-2.309867,"median":-1.543115,"eighty":-0.742724,"marketCap":191165325},{"date":"2020-12-31","current":-17.084132,"twenty":-2.322388,"median":-1.548046,"eighty":-0.742724,"marketCap":267414498},{"date":"2021-01-08","current":-19.10957,"twenty":-2.333493,"median":-1.548046,"eighty":-0.742724,"marketCap":299118279},{"date":"2021-01-15","current":-21.221638,"twenty":-2.351108,"median":-1.548046,"eighty":-0.742724,"marketCap":332178060},{"date":"2021-01-22","current":-19.541592,"twenty":-2.35963,"median":-1.548046,"eighty":-0.742724,"marketCap":305880630},{"date":"2021-01-29","current":-18.74578,"twenty":-2.377597,"median":-1.548046,"eighty":-0.742724,"marketCap":293423953},{"date":"2021-02-05","current":-17.949969,"twenty":-2.395255,"median":-1.548046,"eighty":-0.742724,"marketCap":280967275},{"date":"2021-02-12","current":-18.054458,"twenty":-2.424455,"median":-1.548046,"eighty":-0.742724,"marketCap":270636328},{"date":"2021-02-19","current":-27.979684,"twenty":-2.444135,"median":-1.559823,"eighty":-0.742724,"marketCap":419415462},{"date":"2021-02-26","current":-23.347912,"twenty":-2.449711,"median":-1.559823,"eighty":-0.742724,"marketCap":349985200},{"date":"2021-03-05","current":-20.134029,"twenty":-2.470472,"median":-1.558206,"eighty":-0.742674,"marketCap":301809099},{"date":"2021-03-12","current":-22.2136,"twenty":-2.499151,"median":-1.561745,"eighty":-0.742674,"marketCap":332981870},{"date":"2021-03-19","current":-22.471645,"twenty":-2.519736,"median":-1.561745,"eighty":-0.742674,"marketCap":336849963},{"date":"2021-03-26","current":-20.559165,"twenty":-2.555481,"median":-1.563666,"eighty":-0.742724,"marketCap":308181881},{"date":"2021-04-01","current":-20.941661,"twenty":-2.570852,"median":-1.563666,"eighty":-0.742724,"marketCap":313915497},{"date":"2021-04-09","current":-20.654789,"twenty":-2.606601,"median":-1.561745,"eighty":-0.742674,"marketCap":309615285},{"date":"2021-04-16","current":-19.602925,"twenty":-2.636028,"median":-1.561745,"eighty":-0.742674,"marketCap":293847840},{"date":"2021-04-23","current":-19.507301,"twenty":-2.644829,"median":-1.561745,"eighty":-0.742674,"marketCap":292414436},{"date":"2021-04-30","current":-32.079325,"twenty":-2.679147,"median":-1.561745,"eighty":-0.742674,"marketCap":480869082},{"date":"2021-05-07","current":-32.586508,"twenty":-2.685764,"median":-1.561745,"eighty":-0.742674,"marketCap":488471755},{"date":"2021-05-14","current":-27.134291,"twenty":-2.72478,"median":-1.583089,"eighty":-0.742674,"marketCap":406743018},{"date":"2021-05-21","current":-35.756402,"twenty":-2.752079,"median":-1.598123,"eighty":-0.742674,"marketCap":535988463},{"date":"2021-05-28","current":-32.8401,"twenty":-2.768658,"median":-1.630931,"eighty":-0.742674,"marketCap":492273092},{"date":"2021-06-04","current":-30.557776,"twenty":-2.77947,"median":-1.651439,"eighty":-0.742674,"marketCap":458061062},{"date":"2021-06-11","current":-35.50281,"twenty":-2.792773,"median":-1.67478,"eighty":-0.742674,"marketCap":532187126},{"date":"2021-06-18","current":-36.643972,"twenty":-2.812661,"median":-1.694545,"eighty":-0.742674,"marketCap":549293141},{"date":"2021-06-25","current":-33.600874,"twenty":-2.818394,"median":-1.70616,"eighty":-0.742823,"marketCap":503677102},{"date":"2021-07-02","current":-36.175919,"twenty":-2.835565,"median":-1.70616,"eighty":-0.742823,"marketCap":648786166},{"date":"2021-07-09","current":-33.081224,"twenty":-2.85862,"median":-1.70616,"eighty":-0.742823,"marketCap":593285285},{"date":"2021-07-16","current":-29.239533,"twenty":-2.885827,"median":-1.70616,"eighty":-0.742823,"marketCap":524387639},{"date":"2021-07-23","current":-30.62681,"twenty":-2.916894,"median":-1.70616,"eighty":-0.742823,"marketCap":549267344},{"date":"2021-07-30","current":-28.492113,"twenty":-2.924134,"median":-1.70616,"eighty":-0.742823,"marketCap":510983246},{"date":"2021-08-06","current":-29.777471,"twenty":-2.938849,"median":-1.715533,"eighty":-0.742823,"marketCap":534035122},{"date":"2021-08-13","current":-23.693959,"twenty":-2.968928,"median":-1.732484,"eighty":-0.743545,"marketCap":534343791},{"date":"2021-08-20","current":-23.009657,"twenty":-3.016018,"median":-1.747566,"eighty":-0.760103,"marketCap":518911480},{"date":"2021-08-27","current":-26.089016,"twenty":-3.058487,"median":-1.763279,"eighty":-0.772114,"marketCap":588356882},{"date":"2021-09-03","current":-27.029931,"twenty":-3.093037,"median":-1.773644,"eighty":-0.779499,"marketCap":609576311},{"date":"2021-09-10","current":-25.832403,"twenty":-3.133777,"median":-1.781251,"eighty":-0.779499,"marketCap":582569765},{"date":"2021-09-17","current":-25.490252,"twenty":-3.173766,"median":-1.800291,"eighty":-0.779499,"marketCap":574853610},{"date":"2021-09-24","current":-24.207185,"twenty":-3.204832,"median":-1.822788,"eighty":-0.779499,"marketCap":545918025},{"date":"2021-10-01","current":-23.009657,"twenty":-3.282133,"median":-1.835745,"eighty":-0.779499,"marketCap":518911480},{"date":"2021-10-08","current":-21.555515,"twenty":-3.313145,"median":-1.858529,"eighty":-0.779499,"marketCap":486117817},{"date":"2021-10-15","current":-20.443524,"twenty":-3.350636,"median":-1.873762,"eighty":-0.779499,"marketCap":461040311},{"date":"2021-10-22","current":-19.759222,"twenty":-3.375442,"median":-1.904318,"eighty":-0.779499,"marketCap":445607999},{"date":"2021-10-29","current":-19.588146,"twenty":-3.418203,"median":-1.917993,"eighty":-0.779499,"marketCap":441749921},{"date":"2021-11-05","current":-21.127826,"twenty":-3.45338,"median":-1.936117,"eighty":-0.779578,"marketCap":476472623},{"date":"2021-11-12","current":-13.833383,"twenty":-3.484535,"median":-1.960234,"eighty":-0.80279,"marketCap":443339179},{"date":"2021-11-19","current":-13.646446,"twenty":-3.554592,"median":-1.974573,"eighty":-0.825259,"marketCap":437348109},{"date":"2021-11-26","current":-12.150945,"twenty":-3.639335,"median":-1.987522,"eighty":-0.828653,"marketCap":389419549},{"date":"2021-12-03","current":-10.406194,"twenty":-3.687422,"median":-2.014852,"eighty":-0.83885,"marketCap":333502896},{"date":"2021-12-10","current":-11.465507,"twenty":-3.752188,"median":-2.030447,"eighty":-0.842198,"marketCap":367452292},{"date":"2021-12-17","current":-11.777069,"twenty":-7.994202,"median":-2.037895,"eighty":-0.845526,"marketCap":377437409},{"date":"2021-12-23","current":-12.649445,"twenty":-11.091631,"median":-2.047717,"eighty":-0.849351,"marketCap":405395735},{"date":"2021-12-31","current":-12.150945,"twenty":-11.492175,"median":-2.058463,"eighty":-0.853568,"marketCap":389419549},{"date":"2022-01-07","current":-10.967006,"twenty":-11.590132,"median":-2.071065,"eighty":-0.859381,"marketCap":351476106},{"date":"2022-01-14","current":-10.842381,"twenty":-11.590132,"median":-2.072974,"eighty":-0.867858,"marketCap":347482059},{"date":"2022-01-21","current":-9.34688,"twenty":-11.590132,"median":-2.080397,"eighty":-0.869049,"marketCap":299553499},{"date":"2022-01-28","current":-9.596131,"twenty":-11.590132,"median":-2.089644,"eighty":-0.874837,"marketCap":307541592},{"date":"2022-02-04","current":-9.34688,"twenty":-11.590132,"median":-2.097879,"eighty":-0.880305,"marketCap":299553499},{"date":"2022-02-11","current":-8.308777,"twenty":-11.590132,"median":-2.106527,"eighty":-0.889608,"marketCap":309791932},{"date":"2022-02-18","current":-7.699467,"twenty":-11.590132,"median":-2.119816,"eighty":-0.895159,"marketCap":287073857},{"date":"2022-02-25","current":-7.754859,"twenty":-11.590132,"median":-2.123135,"eighty":-0.900425,"marketCap":289139137},{"date":"2022-03-04","current":-6.813197,"twenty":-11.590132,"median":-2.131195,"eighty":-0.912803,"marketCap":254029384},{"date":"2022-03-11","current":-6.59163,"twenty":-11.590132,"median":-2.138746,"eighty":-0.928191,"marketCap":245768266},{"date":"2022-03-18","current":-6.813197,"twenty":-11.590132,"median":-2.144456,"eighty":-0.948857,"marketCap":254029384},{"date":"2022-03-25","current":-6.536238,"twenty":-11.590132,"median":-2.154957,"eighty":-0.957849,"marketCap":243702986},{"date":"2022-04-01","current":-6.370063,"twenty":-11.590132,"median":-2.169872,"eighty":-0.963752,"marketCap":237507148},{"date":"2022-04-08","current":-7.533291,"twenty":-11.590132,"median":-2.178195,"eighty":-0.973722,"marketCap":280878018},{"date":"2022-04-14","current":-8.97348,"twenty":-11.590132,"median":-2.185127,"eighty":-0.983853,"marketCap":334575287},{"date":"2022-04-22","current":-7.699467,"twenty":-11.590132,"median":-2.196891,"eighty":-0.995258,"marketCap":287073857},{"date":"2022-04-29","current":-7.034765,"twenty":-11.590132,"median":-2.203547,"eighty":-1.006149,"marketCap":262290502},{"date":"2022-05-06","current":-7.034765,"twenty":-11.590132,"median":-2.215938,"eighty":-1.021031,"marketCap":262290502},{"date":"2022-05-13","current":-6.314671,"twenty":-11.590132,"median":-2.22671,"eighty":-1.027995,"marketCap":235441868},{"date":"2022-05-20","current":-5.816144,"twenty":-11.590132,"median":-2.236341,"eighty":-1.039985,"marketCap":216854352},{"date":"2022-05-27","current":-5.871536,"twenty":-11.590132,"median":-2.249837,"eighty":-1.053264,"marketCap":218919632},{"date":"2022-06-03","current":-6.370063,"twenty":-11.590132,"median":-2.25698,"eighty":-1.079422,"marketCap":237507148},{"date":"2022-06-10","current":-5.539185,"twenty":-11.590132,"median":-2.268657,"eighty":-1.093745,"marketCap":206527955},{"date":"2022-06-17","current":-5.475484,"twenty":-11.590132,"median":-2.28141,"eighty":-1.100513,"marketCap":204152883},{"date":"2022-06-24","current":-4.256347,"twenty":-11.590132,"median":-2.296391,"eighty":-1.115309,"marketCap":203293371},{"date":"2022-07-01","current":-3.773085,"twenty":-11.590132,"median":-2.321872,"eighty":-1.145312,"marketCap":180211576},{"date":"2022-07-08","current":-4.027479,"twenty":-11.590132,"median":-2.324352,"eighty":-1.154027,"marketCap":192362065},{"date":"2022-07-15","current":-3.375053,"twenty":-11.590132,"median":-2.341195,"eighty":-1.170145,"marketCap":161200608},{"date":"2022-07-22","current":-0.648533,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30975479},{"date":"2022-07-29","current":-0.619113,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29570320},{"date":"2022-08-05","current":-0.670165,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32008683},{"date":"2022-08-12","current":-0.544468,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32556040},{"date":"2022-08-19","current":-0.743715,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":44469814},{"date":"2022-08-26","current":-0.656198,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39236854},{"date":"2022-09-02","current":-0.606387,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":36258411},{"date":"2022-09-09","current":-0.715004,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":42753072},{"date":"2022-09-16","current":-0.660695,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39505741},{"date":"2022-09-23","current":-0.56038,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-09-30","current":-0.526135,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":31459808},{"date":"2022-10-07","current":-0.490506,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29329393},{"date":"2022-10-14","current":-0.38604,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":23082936},{"date":"2022-10-21","current":-0.366323,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":21903968},{"date":"2022-10-28","current":-0.449689,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":26888802},{"date":"2022-11-04","current":-0.428934,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25647781},{"date":"2022-11-11","current":-0.519633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-11-18","current":-0.47633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30715197},{"date":"2022-11-25","current":-0.389404,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25109932},{"date":"2022-12-02","current":-0.434631,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":28026324},{"date":"2022-12-09","current":-0.37529,"twenty":-11.590132,"median":-2.359022,"eighty":-1.172623,"marketCap":24199852},{"date":"2022-12-16","current":-0.471519,"twenty":-11.590132,"median":-2.359022,"eighty":-1.16627,"marketCap":30404942},{"date":"2022-12-23","current":-0.313384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.150476,"marketCap":20207910},{"date":"2022-12-30","current":-0.330384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.132526,"marketCap":21304143},{"date":"2023-01-06","current":-0.521557,"twenty":-11.590132,"median":-2.359022,"eighty":-1.111492,"marketCap":33631589},{"date":"2023-01-13","current":-0.513218,"twenty":-11.590132,"median":-2.359022,"eighty":-1.099507,"marketCap":33093815},{"date":"2023-01-20","current":-0.549143,"twenty":-11.590132,"median":-2.359022,"eighty":-1.093055,"marketCap":35410382},{"date":"2023-01-27","current":-0.679693,"twenty":-11.590132,"median":-2.341195,"eighty":-1.07824,"marketCap":43828621},{"date":"2023-02-03","current":-0.962283,"twenty":-11.590132,"median":-2.341031,"eighty":-1.04899,"marketCap":62050903},{"date":"2023-02-10","current":-0.620017,"twenty":-11.590132,"median":-2.341031,"eighty":-1.039212,"marketCap":39500707},{"date":"2023-02-17","current":-0.677853,"twenty":-11.590132,"median":-2.341031,"eighty":-1.026755,"marketCap":43185392},{"date":"2023-02-24","current":-0.614509,"twenty":-11.590132,"median":-2.341031,"eighty":-1.020438,"marketCap":39149784},{"date":"2023-03-03","current":-0.584213,"twenty":-11.590132,"median":-2.341031,"eighty":-1.006123,"marketCap":37219711},{"date":"2023-03-10","current":-0.461656,"twenty":-11.590132,"median":-2.324352,"eighty":-0.995052,"marketCap":29411687},{"date":"2023-03-17","current":-0.475426,"twenty":-11.590132,"median":-2.324352,"eighty":-0.983843,"marketCap":30288982},{"date":"2023-03-24","current":-0.47818,"twenty":-11.590132,"median":-2.324352,"eighty":-0.969566,"marketCap":30464443},{"date":"2023-03-31","current":-0.429295,"twenty":-11.590132,"median":-2.323112,"eighty":-0.962219,"marketCap":27350007},{"date":"2023-04-06","current":-0.456836,"twenty":-11.590132,"median":-2.323112,"eighty":-0.957849,"marketCap":29104619},{"date":"2023-04-14","current":-0.479902,"twenty":-11.590132,"median":-2.324352,"eighty":-0.948422,"marketCap":30574106},{"date":"2023-04-21","current":-0.486098,"twenty":-11.590132,"median":-2.324352,"eighty":-0.920451,"marketCap":30968894},{"date":"2023-04-28","current":-0.470607,"twenty":-11.590132,"median":-2.324352,"eighty":-0.896953,"marketCap":29981925},{"date":"2023-05-05","current":-0.432394,"twenty":-11.590132,"median":-2.324352,"eighty":-0.887332,"marketCap":27547401},{"date":"2023-05-12","current":-0.493328,"twenty":-11.590132,"median":-2.324352,"eighty":-0.868084,"marketCap":31429479},{"date":"2023-05-19","current":-0.48782,"twenty":-11.590132,"median":-2.324352,"eighty":-0.858687,"marketCap":31078557},{"date":"2023-05-26","current":-0.454771,"twenty":-11.590132,"median":-2.321872,"eighty":-0.847383,"marketCap":28973023},{"date":"2023-06-02","current":-0.486098,"twenty":-11.590132,"median":-2.296391,"eighty":-0.842823,"marketCap":30968894},{"date":"2023-06-09","current":-0.290328,"twenty":-11.590132,"median":-2.281329,"eighty":-0.831263,"marketCap":18496511},{"date":"2023-06-16","current":-0.238688,"twenty":-11.590132,"median":-2.262443,"eighty":-0.82638,"marketCap":15206617},{"date":"2023-06-23","current":-0.200819,"twenty":-11.590132,"median":-2.248215,"eighty":-0.803176,"marketCap":12794029},{"date":"2023-06-30","current":-0.239173,"twenty":-11.590132,"median":-2.248215,"eighty":-0.790862,"marketCap":14170462},{"date":"2023-07-07","current":-0.265748,"twenty":-11.590132,"median":-2.239504,"eighty":-0.779697,"marketCap":15744958},{"date":"2023-07-14","current":-0.239173,"twenty":-11.590132,"median":-2.233935,"eighty":-0.766212,"marketCap":14170462},{"date":"2023-07-21","current":-0.248474,"twenty":-11.590132,"median":-2.228997,"eighty":-0.754142,"marketCap":14721535},{"date":"2023-07-28","current":-0.223228,"twenty":-11.590132,"median":-2.228997,"eighty":-0.724814,"marketCap":13225764},{"date":"2023-08-04","current":-0.229111,"twenty":-11.590132,"median":-2.228997,"eighty":-0.710284,"marketCap":13574287},{"date":"2023-08-11","current":-1.293951,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":60006335},{"date":"2023-08-18","current":-1.117918,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":51842887},{"date":"2023-08-25","current":-1.121954,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":52030046},{"date":"2023-09-01","current":-1.075542,"twenty":-11.590132,"median":-2.20645,"eighty":-0.708289,"marketCap":49877724},{"date":"2023-09-08","current":-1.32778,"twenty":-11.590132,"median":-2.204979,"eighty":-0.708289,"marketCap":61575126},{"date":"2023-09-15","current":-1.24101,"twenty":-11.590132,"median":-2.191847,"eighty":-0.708289,"marketCap":57551220},{"date":"2023-09-22","current":-1.03922,"twenty":-11.590132,"median":-2.171822,"eighty":-0.708289,"marketCap":48193298},{"date":"2023-09-29","current":-1.045273,"twenty":-11.590132,"median":-2.122085,"eighty":-0.708289,"marketCap":48474035},{"date":"2023-10-06","current":-1.636861,"twenty":-11.590132,"median":-2.080397,"eighty":-0.708289,"marketCap":75908600},{"date":"2023-10-13","current":-1.760348,"twenty":-11.590132,"median":-2.052187,"eighty":-0.708289,"marketCap":81635252},{"date":"2023-10-20","current":-1.581686,"twenty":-11.590132,"median":-2.0251,"eighty":-0.708289,"marketCap":73349883},{"date":"2023-10-23","current":-1.565921,"twenty":-11.590132,"median":-2.024672,"eighty":-0.708289,"marketCap":72618821},{"date":"2023-11-03","current":-1.723564,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":79929440},{"date":"2023-11-10","current":-1.684041,"twenty":-11.590132,"median":-1.950372,"eighty":-0.702187,"marketCap":78096579},{"date":"2023-11-17","current":-2.528721,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":89716486},{"date":"2023-11-24","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-01","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-08","current":-3.709298,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":131602195},{"date":"2023-12-15","current":-3.777848,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":134034268},{"date":"2023-12-22","current":-3.884481,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":137817493},{"date":"2023-12-29","current":-3.991114,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":141600719},{"date":"2024-01-05","current":-3.876864,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":137547263},{"date":"2024-01-12","current":-4.151063,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":147275557},{"date":"2024-01-19","current":-3.655982,"twenty":-11.590132,"median":-1.925948,"eighty":-0.698735,"marketCap":129710582},{"date":"2024-01-26","current":-3.671215,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":130251043},{"date":"2024-02-02","current":-3.655982,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":129710582},{"date":"2024-02-09","current":-3.770231,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":133764038},{"date":"2024-02-16","current":-4.567745,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":146476632},{"date":"2024-02-23","current":-4.146367,"twenty":-11.590132,"median":-1.962469,"eighty":-0.700461,"marketCap":132964028},{"date":"2024-03-01","current":-4.306491,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":138098817},{"date":"2024-03-08","current":-3.569078,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":114451760},{"date":"2024-03-15","current":-3.303609,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":105938819},{"date":"2024-03-22","current":-3.552223,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":113911255},{"date":"2024-03-28","current":-3.851402,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":123505205},{"date":"2024-04-05","current":-4.458187,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":142963355},{"date":"2024-04-12","current":-4.470828,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":143368733},{"date":"2024-04-19","current":-3.96096,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":127018482},{"date":"2024-04-26","current":-3.96096,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":127018482},{"date":"2024-05-03","current":-3.71656,"twenty":-11.590132,"median":-2.022834,"eighty":-0.702187,"marketCap":119181171},{"date":"2024-05-10","current":-3.775553,"twenty":-11.590132,"median":-2.06822,"eighty":-0.702187,"marketCap":121072936},{"date":"2024-05-17","current":-3.834546,"twenty":-11.590132,"median":-2.260612,"eighty":-0.702187,"marketCap":122964700},{"date":"2024-05-24","current":-3.455306,"twenty":-11.590132,"median":-2.481343,"eighty":-0.702187,"marketCap":110803356},{"date":"2024-05-31","current":-3.278327,"twenty":-11.590132,"median":-2.528721,"eighty":-0.702187,"marketCap":105128063},{"date":"2024-06-07","current":-3.253044,"twenty":-11.590132,"median":-2.569513,"eighty":-0.702187,"marketCap":104317306},{"date":"2024-06-14","current":-3.239859,"twenty":-11.590132,"median":-2.650451,"eighty":-0.700461,"marketCap":95128735},{"date":"2024-06-21","current":-2.963734,"twenty":-11.590132,"median":-2.695417,"eighty":-0.698735,"marketCap":87021172},{"date":"2024-06-28","current":-3.203042,"twenty":-11.590132,"median":-2.73437,"eighty":-0.693557,"marketCap":94047727},{"date":"2024-07-05","current":-3.046572,"twenty":-11.590132,"median":-2.762551,"eighty":-0.693557,"marketCap":89453441},{"date":"2024-07-12","current":-3.59882,"twenty":-11.590132,"median":-2.788793,"eighty":-0.693557,"marketCap":105668567},{"date":"2024-07-15","current":-3.534391,"twenty":-11.590132,"median":-2.795067,"eighty":-0.693557,"marketCap":103776802},{"date":"2024-08-02","current":-3.100103,"twenty":-11.814457,"median":-2.833386,"eighty":-0.682688,"marketCap":91025218},{"date":"2024-08-09","current":-3.14156,"twenty":-11.814457,"median":-2.87737,"eighty":-0.682688,"marketCap":92242494},{"date":"2024-08-16","current":-2.755069,"twenty":-11.814457,"median":-2.894519,"eighty":-0.682688,"marketCap":91446261},{"date":"2024-08-23","current":-2.975149,"twenty":-11.814457,"median":-2.918362,"eighty":-0.682688,"marketCap":98751140},{"date":"2024-08-30","current":-2.869185,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":95233976},{"date":"2024-09-06","current":-2.657256,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":88199648},{"date":"2024-09-13","current":-2.600199,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":86305791},{"date":"2024-09-20","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-09-27","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-10-04","current":-2.404572,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":79812565},{"date":"2024-10-11","current":-2.46163,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81706423},{"date":"2024-10-18","current":-2.494234,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":82788627},{"date":"2024-10-25","current":-2.469781,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81976974},{"date":"2024-10-31","current":-2.518688,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":83600280},{"date":"2024-11-08","current":-2.543141,"twenty":-11.826919,"median":-2.927982,"eighty":-0.68268,"marketCap":84411933},{"date":"2024-11-15","current":-1.866798,"twenty":-11.826919,"median":-2.927982,"eighty":-0.684226,"marketCap":73860442},{"date":"2024-11-22","current":-1.780462,"twenty":-11.826919,"median":-2.927982,"eighty":-0.711322,"marketCap":70443968},{"date":"2024-11-29","current":-1.998621,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":79075443},{"date":"2024-12-06","current":-1.826205,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72253794},{"date":"2024-12-13","current":-1.745275,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":69051795},{"date":"2024-12-20","current":-1.583415,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":62647798},{"date":"2024-12-27","current":-1.829724,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72393011},{"date":"2025-01-03","current":-2.332897,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":92301089},{"date":"2025-01-10","current":-2.132332,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":84365701},{"date":"2025-01-17","current":-2.05492,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81302920},{"date":"2025-01-24","current":-2.090107,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82695094},{"date":"2025-01-31","current":-2.068995,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81859790},{"date":"2025-02-07","current":-2.019733,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":79910747},{"date":"2025-02-14","current":-1.738893,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82256942},{"date":"2025-02-21","current":-1.751103,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82834183},{"date":"2025-02-28","current":-1.549757,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":73309695},{"date":"2025-03-07","current":-1.629075,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":77061766},{"date":"2025-03-14","current":-1.659582,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":78504871},{"date":"2025-03-21","current":-1.690089,"twenty":-11.851844,"median":-2.928824,"eighty":-0.732399,"marketCap":79947975},{"date":"2025-03-28","current":-1.604669,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":75907283},{"date":"2025-04-04","current":-1.39112,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":65805553},{"date":"2025-04-11","current":-1.250788,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59167274},{"date":"2025-04-17","current":-1.262991,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59744515},{"date":"2025-04-25","current":-1.427729,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":67537278},{"date":"2025-05-02","current":-1.439932,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":68114520},{"date":"2025-05-09","current":-1.372816,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":64939691},{"date":"2025-05-16","current":-1.403323,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":66382795},{"date":"2025-05-23","current":-1.482641,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":70134866},{"date":"2025-05-30","current":-1.555858,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":73598316},{"date":"2025-06-06","current":-1.446033,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":68403141},{"date":"2025-06-13","current":-1.412475,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":66815726},{"date":"2025-06-20","current":-1.168169,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":60064929},{"date":"2025-06-27","current":-1.162499,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":59773352},{"date":"2025-07-03","current":-1.134145,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":58315466},{"date":"2025-07-11","current":-1.377986,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":70853291},{"date":"2025-07-18","current":-1.440364,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":74060641},{"date":"2025-07-25","current":-1.536766,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":79017456},{"date":"2025-08-01","current":-1.627498,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":83682693},{"date":"2025-08-08","current":-1.585392,"twenty":-11.864307,"median":-2.927982,"eighty":-0.737322,"marketCap":81517693},{"date":"2025-08-15","current":-1.625328,"twenty":-11.864307,"median":-2.915434,"eighty":-0.737322,"marketCap":90660791},{"date":"2025-08-22","current":-1.683081,"twenty":-11.864307,"median":-2.877336,"eighty":-0.737322,"marketCap":93882241},{"date":"2025-08-29","current":-1.776585,"twenty":-11.864307,"median":-2.863852,"eighty":-0.737322,"marketCap":99097921},{"date":"2025-09-05","current":-1.991095,"twenty":-11.876769,"median":-2.857435,"eighty":-0.736288,"marketCap":111063305},{"date":"2025-09-12","current":-1.925092,"twenty":-11.864307,"median":-2.851018,"eighty":-0.737322,"marketCap":107381648},{"date":"2025-09-19","current":-1.67208,"twenty":-11.864307,"median":-2.851018,"eighty":-0.737322,"marketCap":93268631},{"date":"2025-09-26","current":-1.853589,"twenty":-11.864307,"median":-2.851018,"eighty":-0.737322,"marketCap":103393187},{"date":"2025-10-03","current":-1.980095,"twenty":-11.864307,"median":-2.83596,"eighty":-0.737322,"marketCap":110449695},{"date":"2025-10-10","current":-2.315611,"twenty":-11.864307,"median":-2.802915,"eighty":-0.737322,"marketCap":129164782},{"date":"2025-10-17","current":-2.227607,"twenty":-11.864307,"median":-2.73437,"eighty":-0.737322,"marketCap":124255907},{"date":"2025-10-24","current":-2.28811,"twenty":-11.864307,"median":-2.673112,"eighty":-0.737322,"marketCap":127630759},{"date":"2025-10-31","current":-2.062599,"twenty":-11.864307,"median":-2.649105,"eighty":-0.737322,"marketCap":115051766},{"date":"2025-11-07","current":-2.211106,"twenty":-11.864307,"median":-2.567594,"eighty":-0.737322,"marketCap":123335493},{"date":"2025-11-14","current":-2.0901,"twenty":-11.864307,"median":-2.53499,"eighty":-0.737322,"marketCap":116585789},{"date":"2025-11-21","current":-2.824005,"twenty":-11.864307,"median":-2.526839,"eighty":-0.737322,"marketCap":175754756},{"date":"2025-11-28","current":-3.109578,"twenty":-11.864307,"median":-2.526839,"eighty":-0.737322,"marketCap":193527709},{"date":"2025-12-01","current":-3.109578,"twenty":-11.864307,"median":-2.526839,"eighty":-0.737322,"marketCap":193527709}],"updateTime":1764713310749},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VTGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588778506","title":"BRIEF-Vistagen Appoints Nick Tressler As Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2588778506","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588778506?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:30","pubTimestamp":1764595855,"startTime":"0","endTime":"0","summary":"BRIEF-Vistagen Appoints Nick Tressler As Chief Financial OfficerDec 1 (Reuters) - VistaGen Therapeutics Inc VTGN.O:VISTAGEN APPOINTS NICK TRESSLER AS CHIEF FINANCIAL OFFICERSource text: ID:nBw25GdrJaFurther company coverage: VTGN.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA3LZJSY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2588528778","title":"Vistagen Appoints Nick Tressler as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2588528778","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588528778?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:30","pubTimestamp":1764595801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA3LZJSY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2586250717","title":"Vistagen presents exploratory PH80 data at Menopause Society meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586250717","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586250717?lang=en_us&edition=fundamental","pubTime":"2025-11-26 21:40","pubTimestamp":1764164425,"startTime":"0","endTime":"0","summary":"Vistagen (VTGN) presented exploratory data at The Menopause Society 2025 annual meeting in Orlando, Florida. These findings demonstrate PH80’s pote...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vistagen-presents-exploratory-ph80-data-at-menopause-society-meeting-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vistagen-presents-exploratory-ph80-data-at-menopause-society-meeting-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2586474257","title":"VistaGen Unveils Rapid-Acting PH80 Nasal Spray Data for Menopausal Hot Flashes at Menopause Society Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586474257","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586474257?lang=en_us&edition=fundamental","pubTime":"2025-11-26 21:30","pubTimestamp":1764163820,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. has presented new exploratory data on PH80, a non-hormonal, intranasal product candidate for the treatment of menopausal hot flashes, at The Menopause Society 2025 Annual Meeting. The findings indicate that PH80 induces rapid-onset effects on physiologic markers of autonomic activity within seconds of administration and is not absorbed into the bloodstream. The research further demonstrates that PH80 does not bind to steroid hormone or neurotransmitter receptors and has no observed effects on reproductive organs in preclinical studies. These results support PH80's potential as a rapidly-acting, non-systemic treatment option for vasomotor symptoms associated with menopause. The posters presented are available on the company's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDLWH8jh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2584221319","title":"VistaGen Q2 EPS USD -0.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2584221319","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584221319?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:41","pubTimestamp":1763574107,"startTime":"0","endTime":"0","summary":"Nov 13 (Reuters) - VistaGen Q2 net income USD -19.417 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 13-NOV-202521:21:48.29 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD53n3Zn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2583655126","title":"VistaGen Therapeutics: Buy Rating Backed by Promising Clinical Trials and Stable Financial Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2583655126","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583655126?lang=en_us&edition=fundamental","pubTime":"2025-11-15 23:45","pubTimestamp":1763221523,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCarthy from Maxim Group mai...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vistagen-therapeutics-buy-rating-backed-by-promising-clinical-trials-and-stable-financial-outlook-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vistagen-therapeutics-buy-rating-backed-by-promising-clinical-trials-and-stable-financial-outlook-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VTGN"],"gpt_icon":0},{"id":"2583545640","title":"VistaGen Therapeutics: Buy Rating Affirmed Amid Promising Fasedienol Trials and Market Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2583545640","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583545640?lang=en_us&edition=fundamental","pubTime":"2025-11-14 07:45","pubTimestamp":1763077521,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their bullish stance on VTGN stock, giving a Buy rating on November 3. Myles Minter has given his...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vistagen-therapeutics-buy-rating-affirmed-amid-promising-fasedienol-trials-and-market-potential-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vistagen-therapeutics-buy-rating-affirmed-amid-promising-fasedienol-trials-and-market-potential-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VTGN"],"gpt_icon":0},{"id":"2583022512","title":"Biopharmaceutical firm VistaGen's fiscal Q2 net loss widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2583022512","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583022512?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:38","pubTimestamp":1763069937,"startTime":"0","endTime":"0","summary":"Biopharmaceutical firm VistaGen's fiscal Q2 net loss widensOverviewVistaGen fiscal Q2 net loss widens to $19.4 mln from $13.0 mln year-over-yearR&D expenses increased to $15.9 mln, driven by PALISADE ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL1N3WP1AW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2583951245","title":"BRIEF-VistaGen Q2 EPS USD -0.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2583951245","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583951245?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:30","pubTimestamp":1763069446,"startTime":"0","endTime":"0","summary":"BRIEF-VistaGen Q2 EPS USD -0.54\n\n\nNov 13 (Reuters) - VistaGen Q2 net income USD -19.417 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX267A2B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2583450512","title":"VistaGen Therapeutics reports fiscal Q2 net loss and higher R&D expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2583450512","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583450512?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:30","pubTimestamp":1763069437,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. reported a research and development expense of $15.9 million for the three months ended September 30, 2025, up from $10.2 million in the same period in 2024. General and administrative expense was $4.4 million, compared to $4.2 million the previous year. As of September 30, 2025, the company had $77.2 million in cash, cash equivalents, and marketable securities. During the period, VistaGen completed the PALISADE-3 Phase 3 Public Speaking Challenge Study of fasedienol for acute treatment of social anxiety disorder, with topline results expected by year-end. The company also appointed Paul Edick to its Board of Directors and to its Audit and Compensation Committees.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDLqFvmw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2582743548","title":"Press Release: Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2582743548","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582743548?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:34","pubTimestamp":1762781640,"startTime":"0","endTime":"0","summary":"Vistagen , a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will host a conference call and webcast on Thursday, November 13, 2025, at 2:00 p.m. Pacific Time  to report results for its fiscal year 2026 second quarter ended September 30, 2025, and provide a corporate update.The conference call is being webcast live, and a link can be found under \"Events\" in the Investors section of the Company's website. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes before the call. The webcast will be archived on Vistagen's website shortly after the call and will be available for at least 90 days.For participants interested in joining the call via dial-in, please use the details below.Vistagen is passionate about developing transformative treatment options to improve the lives of i","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4218","BK4588","BK4181","BK4585","HST","VTGN"],"gpt_icon":0},{"id":"2582871065","title":"VistaGen Therapeutics Inc. to Release Fiscal Year 2026 Second Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2582871065","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582871065?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:30","pubTimestamp":1762781444,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. will report its fiscal year 2026 second quarter results on November 13, 2025. Results will be released via a live webcast available under \"Events\" in the Investors section of the Company's website. The webcast will be archived on Vistagen's website for at least 90 days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on November 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL3ls04H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2581778681","title":"VistaGen Therapeutics CEO to Join Stifel Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2581778681","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581778681?lang=en_us&edition=fundamental","pubTime":"2025-11-05 21:30","pubTimestamp":1762349438,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. will participate in a fireside chat presentation at the Stifel Healthcare Conference on November 12. President and CEO Shawn Singh will represent the company, which focuses on developing intranasal neurocircuitry product candidates called pherines. A live webcast of the presentation will be available on the company's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on November 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDLc8Cxwx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SF","BK4139","VTGN","BK4127"],"gpt_icon":0},{"id":"2581762176","title":"VistaGen Therapeutics Inc. Files Initial Beneficial Ownership Statement for Director Paul R. Edick","url":"https://stock-news.laohu8.com/highlight/detail?id=2581762176","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581762176?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:34","pubTimestamp":1762292047,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing names Paul R. Edick as the beneficial owner in his capacity as a director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL3q18cl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2581321757","title":"VistaGen Therapeutics: Promising Prospects for Fasedienol in Social Anxiety Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2581321757","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581321757?lang=en_us&edition=fundamental","pubTime":"2025-11-05 01:55","pubTimestamp":1762278919,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on VistaGen Therapeutics, with a price target of $12.00. Ja...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vistagen-therapeutics-promising-prospects-for-fasedienol-in-social-anxiety-disorder-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vistagen-therapeutics-promising-prospects-for-fasedienol-in-social-anxiety-disorder-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2580249510","title":"Assessing Vistagen Therapeutics’s (VTGN) Valuation After Board Addition of Pharma Executive Paul Edick","url":"https://stock-news.laohu8.com/highlight/detail?id=2580249510","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580249510?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:24","pubTimestamp":1762179858,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics (VTGN) just named Paul Edick to its Board of Directors, bringing an executive with decades of pharmaceutical leadership to the team. Edick will join the Audit and Compensation Committees.\nSee our latest analysis for Vistagen Therapeutics.\nMomentum has picked up for Vistagen Therapeutics lately, with the share price climbing nearly 35% over the past three months and putting its year-to-date share price return just under 19%. While the stock’s one-year total shareholder...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vtgn/vistagen-therapeutics/news/assessing-vistagen-therapeuticss-vtgn-valuation-after-board","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vtgn/vistagen-therapeutics/news/assessing-vistagen-therapeuticss-vtgn-valuation-after-board","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2580249215","title":"Vistagen Therapeutics Inc - Completes Palisade-3 Phase 3 Study for Social Anxiety","url":"https://stock-news.laohu8.com/highlight/detail?id=2580249215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580249215?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:31","pubTimestamp":1762176679,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nFWN3WF20C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2580152222","title":"Vistagen Therapeutics Inc - Topline Results Expected by Year End","url":"https://stock-news.laohu8.com/highlight/detail?id=2580152222","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580152222?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:31","pubTimestamp":1762176679,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nFWN3WF20C:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2580215252","title":"VistaGen Completes Phase 3 Trial of Fasedienol for Social Anxiety Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2580215252","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580215252?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:30","pubTimestamp":1762176645,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. announced the completion of the randomized, double-blind, placebo-controlled portion of the PALISADE-3 Phase 3 clinical trial evaluating fasedienol for the acute treatment of social anxiety disorder. The trial used a public speaking challenge study design to assess the efficacy and safety of a single dose of fasedienol, with the Subjective Units of Distress Scale as the primary endpoint. The open-label extension of the study is ongoing, allowing subjects to use fasedienol for up to twelve months. Topline results from PALISADE-3 are expected later this quarter. The company previously reported positive results from the PALISADE-2 Phase 3 trial and anticipates topline results from the PALISADE-4 Phase 3 trial in the first half of 2026. The FDA has granted Fast Track designation for fasedienol in this indication.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and time","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDLbNh57s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2580866213","title":"William Blair Remains a Buy on VistaGen Therapeutics (VTGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2580866213","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580866213?lang=en_us&edition=fundamental","pubTime":"2025-11-03 20:55","pubTimestamp":1762174550,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter reiterated a Buy rating on VistaGen Therapeutics on November 1. The company’s shares closed last Friday at $3.94...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-remains-a-buy-on-vistagen-therapeutics-vtgn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-remains-a-buy-on-vistagen-therapeutics-vtgn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VTGN"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}]}}